|
| | Rosuvastatin EP impurity H Basic information |
| Product Name: | Rosuvastatin EP impurity H | | Synonyms: | Rosuvastatin EP impurity H;(3R,5RS)-5-[8-uoro-2-[methyl(methylsulfonyl)amino]-4-(propan-2-yl)-5,6-
dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid;Rosuvastatin calcium EP Impurity H;Rosuvastatin Impurity H Sodium Salt (Mixture of Diastereomers);(3R,5RS)-5-[8-Fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoicacid calcium salt;Rosuvastatin Impurity QR;ppRSV;Rosuvastation Impurity H (Calcium salt) | | CAS: | 1335110-44-5 | | MF: | C22H28FN3O6S | | MW: | 481.54 | | EINECS: | | | Product Categories: | | | Mol File: | 1335110-44-5.mol |  |
| | Rosuvastatin EP impurity H Chemical Properties |
| Boiling point | 719.2±70.0 °C(Predicted) | | density | 1.412±0.06 g/cm3(Predicted) | | solubility | Methanol (Slightly), Water (Slightly) | | pka | 4.28±0.10(Predicted) | | form | Solid | | color | White to Off-White | | Stability: | Hygroscopic |
| | Rosuvastatin EP impurity H Usage And Synthesis |
| Uses | (βR,δS)-8-Fluoro-5,6-dihydro-β,δ-dihydroxy-4-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-benzo[h]quinazoline-6-pentanoic Acid Sodium Salt (Rosuvastatin EP Impurity H) is a derived from rosuvastatin, which is a lipid-lowering drug that decomposes under solar irradiation yielding stable dihydrophenanthene analogs. |
| | Rosuvastatin EP impurity H Preparation Products And Raw materials |
|
